We are here to extend our lives by THINKING DIFFERENT

Wednesday, April 22, 2009

Omalizumab for treatment of ABPA exacerbations in CF patients.


Omalizumab for treatment of ABPA exacerbations in CF patients.

Lebecque P, Leonard A, Pilette C.

Pediatric Pulmonology & Cystic Fibrosis Unit Cliniques St Luc, Université de Louvain Brussels, Belgium.

PMID: 19382216 [PubMed - as supplied by publisher]



This is all I've got - most of these journals require you to pay a heavy fee to subscribe, so I'm not able to get full text. But ask your doc if he or she subscribes or has access to Ped Pulm if you're interested in this study.

I'll continue to work on getting a copy

No comments:

Post a Comment